Maspin is not required for embryonic development or tumour suppression

Nature Communications

Volumn 5, Issue , 2014, Pages

  Teoh, Sonia S Y ^a   Vieusseux, Jessica ^a   Prakash, Monica ^a   Berkowicz, Susan ^a   Luu, Jennii ^a   Bird, Catherina H ^a   Law, Ruby H P ^a   Rosado, Carlos ^a   Price, John T ^a   Whisstock, James C ^a   Bird, Phillip I ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MASPIN; SERINE PROTEINASE INHIBITOR; SERPIN-B5;

BIOINFORMATICS; CANCER; CYTOLOGY; EMBRYONIC DEVELOPMENT; GENE EXPRESSION; RODENT; TUMOR;

ANIMAL EXPERIMENT; ARTICLE; BIOINFORMATICS; CANCER INHIBITION; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR GROWTH; ANIMAL; HUMAN; KNOCKOUT MOUSE; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; EMBRYONIC DEVELOPMENT; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS; SERPINS;

EID: 84892894349     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms4164     Document Type: Article

References (57)

1. Liang, P., Averboukh, L., Keyomarsi, K., Sager, R. & Pardee, A. B. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52, 6966-6968 (1992 (Pubitemid 23006309)
2. Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526-529 (1994 (Pubitemid 24082753)
3. Sheng, S. et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc. Natl Acad. Sci. USA 93, 11669-11674 (1996 (Pubitemid 26347180)
4. Seftor, R. E. et al. Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res. 58, 5681-5685 (1998 (Pubitemid 29006405)
5. Cella, N., Contreras, A., Latha, K., Rosen, J. M. & Zhang, M. Maspin is physically associated with b1 integrin regulating cell adhesion in mammary epithelial cells. FASEB J. 20, 1510-1512 (2006
6. Shi, H. Y., Stafford, L. J., Liu, Z., Liu, M. & Zhang, M. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase. Cell Motil. Cytoskeleton 64, 338-346 (2007 (Pubitemid 46608668)
7. Ngamkitidechakul, C., Warejcka, D. J., Burke, J. M., O'Brien, W. J. & Twining, S. S. Sufficiency of the reactive site loop of maspin for induction of cell-matrix adhesion and inhibition of cell invasion. Conversion of ovalbumin to a maspin-like molecule. J. Biol. Chem. 278, 31796-31806 (2003 (Pubitemid 37048361)
8. Zhang, M., Volpert, O., Shi, Y. H. & Bouck, N. Maspin is an angiogenesis inhibitor. Nat. Med. 6, 196-199 (2000 (Pubitemid 30082365)
9. Li, Z., Shi, H. Y. & Zhang, M. Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis. Oncogene 24, 2008-2019 (2005 (Pubitemid 40516194)
10. Cher, M. L. et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc. Natl Acad. Sci. USA 100, 7847-7852 (2003 (Pubitemid 36760058)
11. Luo, J. L. et al. Nuclear cytokine-Activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446, 690-694 (2007
12. Al-Ayyoubi, M., Schwartz, B. S. & Gettins, P. G. Maspin binds to urokinasetype and tissue-Type plasminogen activator through exosite-exosite interactions. J. Biol. Chem. 282, 19502-19509 (2007 (Pubitemid 47100076)
13. Li, X., Yin, S., Meng, Y., Sakr, W. & Sheng, S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res. 66, 9323-9329 (2006 (Pubitemid 44521155)
14. Gao, F., Shi, H. Y., Daughty, C., Cella, N. & Zhang, M. Maspin plays an essential role in early embryonic development. Development 131, 1479-1489 (2004 (Pubitemid 38559276)
15. Kaiserman, D. et al. Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse. Genomics 79, 349-362 (2002 (Pubitemid 34211943)
16. Teoh, S. S., Wang, H., Risbridger, G. P., Whisstock, J. C. & Bird, P. I. A versatile monoclonal antibody specific to human SERPINB5. Hybridoma (Larchmt) 31, 333-339 (2012
17. Alameda, J. P. et al. Increased IKKalpha expression in the basal layer of the epidermis of transgenic mice enhances the malignant potential of skin tumors. PLoS One 6, e21984 (2011
18. Blacque, O. E. & Worrall, D. M. Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J. Biol. Chem. 277, 10783-10788 (2002 (Pubitemid 34952831)
19. Ngamkitidechakul, C., Burke, J. M., O'Brien, W. J. & Twining, S. S. Maspin: Synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. Invest. Ophthalmol. Vis. Sci. 42, 3135-3141 (2001 (Pubitemid 33740671)
20. Qin, L. & Zhang, M. Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway. J. Biol. Chem. 285, 32360-32369 (2010
21. Teoh, S. S., Whisstock, J. C. & Bird, P. I. Maspin (SERPINB5) is an obligate intracellular serpin. J. Biol. Chem. 285, 10862-10869 (2010
22. Odero-Marah, V. A. et al. Maspin regulates different signaling pathways for motility and adhesion in aggressive breast cancer cells. Cancer Biol. Ther. 2, 398-403 (2003
23. Rodriguez, L. G., Wu, X. & Guan, J. L. Wound-healing assay. Methods Mol. Biol. 294, 23-29 (2005
24. Lampugnani, M. G. Cell migration into a wounded area in vitro. Methods Mol. Biol. 96, 177-182 (1999
25. Benbow, U. et al. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J. Biol. Chem. 274, 25371-25378 (1999
26. Hotary, K., Allen, E., Punturieri, A., Yana, I. & Weiss, S. J. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-Type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149, 1309-1323 (2000 (Pubitemid 30399683)
27. Rhodes, D. R. et al. Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007
28. Salmena, L., Carracedo, A. & Pandolfi, P. P. Tenets of PTEN tumor suppression. Cell 133, 403-414 (2008 (Pubitemid 351622014)
29. Bodenstine, T. M. et al. Maspin: Molecular mechanisms and therapeutic implications. Cancer Metastasis Rev. 31, 529-551 (2012
30. Mohsin, S. K., Zhang, M., Clark, G. M. & Craig Allred, D. Maspin expression in invasive breast cancer: Association with other prognostic factors. J. Pathol. 199, 432-435 (2003 (Pubitemid 36411219)
31. Joensuu, K. M., Leidenius, M. H., Andersson, L. C. & Heikkila, P. S. High expression of maspin is associated with early tumor relapse in breast cancer. Hum. Pathol. 40, 1143-1151 (2009
32. Maass, N. et al. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin. Biochem. 34, 303-307 (2001 (Pubitemid 32607573)
33. Umekita, Y., Ohi, Y., Sagara, Y. & Yoshida, H. Expression of maspin predicts poor prognosis in breast-cancer patients. Int. J. Cancer 100, 452-455 (2002
34. Umekita, Y. & Yoshida, H. Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology 42, 541-545 (2003 (Pubitemid 36688147)
35. Kim, D. H. et al. Association of maspin expression with the high histological grade and lymphocyte-rich stroma in early-stage breast cancer. Histopathology 42, 37-42 (2003 (Pubitemid 36062565)
36. Gyorffy, B. et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res. Treat. 123, 725-731 (2010
37. Scacheri, P. C. et al. Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30, 259-263 (2001 (Pubitemid 32816509)
38. Olson, E. N., Arnold, H. H., Rigby, P. W. & Wold, B. J. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4. Cell 85, 1-4 (1996 (Pubitemid 26116800)
39. Pham, C. T., MacIvor, D. M., Hug, B. A., Heusel, J. W. & Ley, T. J. Long-range disruption of gene expression by a selectable marker cassette. Proc. Natl Acad. Sci. USA 93, 13090-13095 (1996 (Pubitemid 26382774)
40. Scarff, K. L., Ung, K. S., Sun, J. & Bird, P. I. A retained selection cassette increases reporter gene expression without affecting tissue distribution in SPI3 knockout/GFP knock-in mice. Genesis 36, 149-157 (2003 (Pubitemid 36959346)
41. Liepinsh, D. J. et al. Novel lymphotoxin alpha (LTalpha) knockout mice with unperturbed tumor necrosis factor expression: Reassessing LTalpha biological functions. Mol. Cell. Biol 26, 4214-4225 (2006 (Pubitemid 43791973)
42. Vaux, D. L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl Acad. Sci. USA 90, 786-789 (1993 (Pubitemid 23053894)
43. O'Neill, A. K., Niederst, M. J. & Newton, A. C. Suppression of survival signalling pathways by the phosphatase PHLPP. FEBS J. 280, 572-583 (2013
44. Miller, A. D., Miller, D. G., Garcia, J. V. & Lynch, C. M. Use of retroviral vectors for gene transfer and expression. Meth. Enzymol. 217, 581-599 (1993
45. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M. & Yee, J. K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl Acad. Sci. USA 90, 8033-8037 (1993 (Pubitemid 23260849)
46. Goulet, B. et al. Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis. Lab. Invest. 91, 1181-1187 (2011
47. Chen, M. et al. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 20, 173-186 (2011
48. Muyrers, J. P., Zhang, Y., Testa, G. & Stewart, A. F. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucl. Acids Res. 27, 1555-1557 (1999 (Pubitemid 29206301)
49. Yagi, T. et al. Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc. Natl Acad. Sci. USA 87, 9918-9922 (1990 (Pubitemid 120016555)
50. Cornacchia, D. et al. Mouse Rif1 is a key regulator of the replication-Timing programme in mammalian cells. EMBO J. 31, 3678-3690 (2012
51. Pasparakis, M. & Kollias, G. Production of cytokine transgenic and knockout mice. In Cytokines: A Practical Approach. (ed.) Balkwill, F. R. (Oxford University Press, 1995
52. Torres, R. M. & Kühn, R. Laboratory protocols for conditional gene targeting (Oxford University Press, 1997
53. Schwenk, F., Baron, U. & Rajewsky, K. A cre-Transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucl. Acids Res. 23, 5080-5081 (1995 (Pubitemid 26012492)
54. Farley, F. W., Soriano, P., Steffen, L. S. & Dymecki, S. M. Widespread recombinase expression using FLPeR (flipper) mice. Genesis 28, 106-110 (2000
55. Li, Q., Mullins, S. R., Sloane, B. F. & Mattingly, R. R. p21-Activated kinase 1 coordinates aberrant cell survival and pericellular proteolysis in a threedimensional culture model for premalignant progression of human breast cancer. Neoplasia 10, 314-329 (2008
56. Law, R. H. et al. The high resolution crystal structure of the human tumor suppressor maspin reveals a novel conformational switch in the G-helix. J. Biol. Chem 280, 22356-22364 (2005 (Pubitemid 40827892)
57. Shaw, L. M. Tumor cell invasion assays. Methods Mol. Biol. 294, 97-105 (2005